HCPLive

Drug Reduces Progression to Clinically Definite MS

Friday, April 20 (HealthDay News) --  As part of a Phase 3 trial, Mark Freedman, M.D., from the University of Ottawa in Canada, and colleagues randomly assigned 517 individuals who had a first clinical demyelinating event and brain lesions detected by magnetic resonance imaging (MRI) to a subcutaneous serum-free formulation of IFN β-1a one or three times a week, or placebo. Placebo patients were switched to IFN β-1a three times a week after two years or after a diagnosis of clinically definite MS.

At three years, the researchers found that the probability of developing clinically definite MS was 41.3 percent for placebo patients switched to IFN β-1a, but was significantly lower for those who received IFN β-1a once a week (27.6 percent) or three times a week (27.1 percent). Similar results were found for the probability of a McDonald MS diagnosis, at 86.5, 79.1, and 66.8 percent, respectively.

"While doses three times a week and once a week equally delayed a clinically definite MS diagnosis without MRI measures, there were significantly more benefits in taking the drug three times a week compared with once a week when it came to brain lesion changes and other McDonald criteria for diagnosing MS," Freedman said in a statement.

The study was supported by Merck Serono S.A.

Press Release
More Information

Individuals suspected of having multiple sclerosis are less likely to be diagnosed with clinically definite disease if they soon start treatment with interferon β-1a, according to a study presented at the annual meeting of the American Academy of Neurology, held from April 21 to 28 in New Orleans.




Copyright © 2012 HealthDay. All rights reserved.

Most Popular

Recommended Reading

The US had been found to have a higher percentage of opioid use than in any other country.
Although the relationship between pain and spatial representation is unclear, a study published in Current Biology took steps in understanding how pain is activated in the brain and raised the possibility of reducing the sensation.
Working in an emergency room setting in the United States, in almost all circumstances provides doctors with at least most of the major needs they require to do their jobs on a daily basis. One organization is working to bring those basic needs to hospitals throughout Latin America.
Patients who choose at-home physical therapy instead of in-patient rehabilitation after knee replacement surgery do just as well when it comes to complications, long-term pain management, and movement recovery, new research indicates. The findings were presented this week at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 24 to 28 in Las Vegas.

$vAR$